drugset / Trial / NCT01175811

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

NCT01175811

Phase 4 Completed 402 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the effects on overall glycaemic control of two insulin intensification therapies.

Timeline

Start
2011-02
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Humalog® Mix25 Protein / enzyme biologic Subcutaneous
Comparator Insulin Lispro Protein / enzyme biologic Subcutaneous
Comparator insulin glargine Protein / enzyme biologic Subcutaneous